Fresenius SE Income from Discontinued Operations 2016-2023 | FSNUY
Fresenius SE annual/quarterly income from discontinued operations history and growth rate from 2016 to 2023. Income from discontinued operations can be defined as income or loss from the complete discontinuation of a segment or business, net of associated taxes and fees.
- Fresenius SE income from discontinued operations for the quarter ending September 30, 2023 was $M, a NAN% increase year-over-year.
- Fresenius SE income from discontinued operations for the twelve months ending September 30, 2023 was $0M, a NAN% increase year-over-year.
- Fresenius SE annual income from discontinued operations for 2022 was $0B, a NAN% decline from 2021.
- Fresenius SE annual income from discontinued operations for 2021 was $0B, a NAN% decline from 2020.
- Fresenius SE annual income from discontinued operations for 2020 was $0B, a NAN% decline from 2019.
Fresenius SE Annual Income from Discontinued Operations
(Millions of US $) |
| 2022 |
$ |
| 2021 |
$ |
| 2020 |
$ |
| 2019 |
$ |
| 2018 |
$ |
| 2017 |
$ |
| 2016 |
$ |
| 2015 |
$ |
Fresenius SE Quarterly Income from Discontinued Operations
(Millions of US $) |
| 2023-09-30 |
|
| 2023-06-30 |
|
| 2023-03-31 |
|
| 2022-12-31 |
|
| 2022-09-30 |
|
| 2022-06-30 |
|
| 2022-03-31 |
|
| 2021-12-31 |
|
| 2021-09-30 |
|
| 2021-06-30 |
|
| 2021-03-31 |
|
| 2020-12-31 |
|
| 2020-09-30 |
|
| 2020-06-30 |
|
| 2020-03-31 |
|
| 2019-12-31 |
|
| 2019-09-30 |
|
| 2019-06-30 |
|
| 2019-03-31 |
|
| 2018-12-31 |
|
| 2018-09-30 |
|
| 2018-06-30 |
|
| 2018-03-31 |
|
| 2017-12-31 |
|
| 2017-09-30 |
|
| 2017-06-30 |
|
| 2017-03-31 |
|
| 2016-12-31 |
|
| 2016-09-30 |
|
| 2016-06-30 |
|
| 2016-03-31 |
|
| 2015-12-31 |
$0 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$21.223B |
$24.011B |
|
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
|
